Abiopharma

Johnson & Johnson - Johnson & Johnson SubmitsOTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration

Ethos and North American Collaborate to Offer Accumulation Indexed Universal Life Product

SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director

bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation

Evaxion to present 2026 company milestones at Biotech Showcase conference in San Francisco next week

Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

SAB BIO Strengthens Board of Directors with Appointment of New Chair and New Director

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference